Our results suggest that oxaliplatin forms biologically relevant interstrand crosslinks (ICLs) in cellular DNA and that loss of the heterodimeric structure-specific endonuclease, XPF-ERCC1, determines the sensitivity of MM cells to oxaliplatin. This evidence concerns the gene ERCC4 and Miyoshi myopathy.